Comorbid Tobacco Dependence and Psychiatric Disorders

Comorbid Tobacco Dependence and Psychiatric Disorders

Contd. from

References

Addington J, el-Guebaly N, Campbell W et al. (1998), Smoking cessation treatment for patients with schizophrenia. Am J Psychiatry 155(7):974-976.

Adler LE, Hoffer LD, Wiser A, Freedman R (1993), Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 150(12):1856-1861.

Benowitz NL, Jacob P III, Ahijevich K et al. (2002), Biochemical verification of tobacco use and cessation. Report from the SRNT Subcommittee on Biochemical Verification. Nicotine Tob Res 4(2):149-159 [see comment].

Brown RA, Kahler CW, Niaura R et al. (2001), Cognitive-behavioral treatment for depression in smoking cessation. J Consult Clin Psychol 69(3):471-480.

Burling TA, Burling AS, Latini D (2001), A controlled smoking cessation trial for substance-dependent inpatients. J Consult Clin Psychol 69(2):295-304.

Burling TA, Salvio MA, Seidner AL, Ramsey TG (1996), Cigarette smoking in alcohol and cocaine abusers. J Subst Abuse 8(4):445-452.

CDC (2004), Cigarette smoking among adults-United States, 2002. MMWR 53(20):427-431.

Chambers RA, Krystal JH, Self DW (2001), A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 50(2):71-83.

Chengappa KN, Kambhampati RK, Perkins K et al. (2001), Bupropion sustained-release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitors. J Clin Psychiatry 62(7):503-508.

Chou KR, Chen R, Lee JF et al. (2004), The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia. Int J Nurs Stud 41(3):321-330.

Cinciripini PM, Lapitsky L, Seay S et al. (1995), A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers. [Published erratum J Clin Psychopharmacol 15(6):408.] J Clin Psychopharmacol 15(3):182-191.

Conners CK, Levin ED, Sparrow E et al. (1996), Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacol Bull 32(1):67-73.

Covey LS, Glassman AH, Stetner F (1997), Major depression following smoking cessation. Am J Psychiatry 154(2):263-265.

Dalack GW, Glassman AH, Rivelli S et al. (1995), Mood, major depression, and fluoxetine response in cigarette smokers. Am J Psychiatry 152(3):398-403.

Dalack GW, Healy DJ, Meador-Woodruff JH (1998), Nicotine dependence and schizophrenia: clinical phenomenon and laboratory findings. Am J Psychiatry 155(11):1490-1501.

Dolan SL, Sacco KA, Termine A et al. (2004), Neuropsychological deficits may predict smoking cessation treatment failure in patients with schizophrenia. Schizophrenia Res 70(2-3):263-275.

Evins AE, Cather C, Deckersbach T et al. (2005), A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. J Clin Psychopharmacol 25(3):218-225.

Evins AE, Mays VK, Rigotti NA et al. (2001), A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine Tob Res 3(4):397-403.

Freedman R, Coon H, Myles-Worsley M et al. (1997), Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Nat Acad Sci U S A 94(2):587-592.

Gentry CL, Lukas RJ (2002), Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure. Curr Drugs Targets CNS Neurol Disord 1(4):359-385.

George TP, Sernyak MJ, Ziedonis DM, Woods SW (1995), Effects of clozapine on smoking in chronic schizophrenic outpatients. J Clin Psychiatry 56(8):344-346.

George TP, Vessicchio JC, Termine A et al. (2002a), Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacol 26(1):75-85 [see comment].

George TP, Vessicchio JC, Termine A et al. (2002b), A placebo-controlled study of bupropion for smoking cessation in schizophrenia. Biol Psychiatry 52(1):53-61.

George TP, Zeidonis DM, Feingold A et al. (2000), Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry 157(11):1835-1842.

Glassman AH, Covey LS, Dalack GW et al. (1993), Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther 54(6):670-679.

Glassman AH, Helzer JE, Covey LS et al. (1990), Smoking, smoking cessation and major depression. JAMA 264(12):1546-1549 [see comment].

Glassman AH, Stetner F, Walsh BT et al. (1988), Heavy smokers, smoking cessation, and clonidine. JAMA 259(19):2863-2866.

Grant BF, Hasin DS, Chou P et al. (2004), Nicotine dependence and psychiatric disorders in the United States. Arch Gen Psychiatry 61(11):1107-1115.

Hall SM, Munoz RF, Reus VI (1994), Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol 62(1):141-146.

Hall SM, Reus VI, Munoz RF et al. (1998), Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry 55(8):683-690 [see comment].

Hayford KE, Patten CA, Rummans TA et al. (1999), Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatry 174:173-178 [see comment].

Hertzberg MA, Moore SD, Feldman ME, Beckham JC (2001), A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder. J Clin Psychopharmacol 21(1):94-98.

Hughes JR (1996), The future of smoking cessation therapy in the United States. Addiction 91(12):1797-1802.

Hurt RD, Offord KP, Croghan IT et al. (1996), Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. [Published erratum JAMA 276(10):784.] JAMA 275(14):1097-1103 [see comments].

Joseph A, Willenbring M, Nugent S, Nelson D (2004), A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. J Stud Alcohol 65(6):681-691.

Kalman D (1998), Smoking cessation treatment for substance misusers in early recovery: a review of the literature and recommendations for practice. Subst Use Misuse 33(10):2021-2047.

Kalman D, Hayes K, Colby SM et al. (2001), Concurrent versus delayed smoking cessation treatment for persons in early alcohol recovery. A pilot study. J Subst Abuse Treat 20(3):233-238.

Kalman D, Kahler C, Tirch D et al. (2004), Twelve-week outcomes from an investigation of high dose nicotine patch therapy for heavy smokers with a past history of alcohol dependence. Psychol Addict Behav 18(1):78-82.

Kalman D, Morrisette SB, George TP (in press), Co-morbidity of smoking with psychiatric and substance use disorders. Am J Addict.

Kendler KS, Neale MC, MacLean CJ et al. (1993), Smoking and major depression: a causal analysis. Arch Gen Psychiatry 50(1):36-43.

Kinnunen T, Doherty K, Militello FS, Garvey AJ (1996), Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement. J Consult Clin Psychol 64(4):791-798.

Lasser K, Boyd JW, Woolhander S et al. (2000), Smoking and mental illness: a population-based prevalence study. JAMA 284(20):2606-2610.

Leonard S, Gault J, Hopkins J et al. (2002), Promoter variants in the alpha-7 nicotinic acetylcholine receptor subunit gene are associated with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry 59(12):1085-1096.

Levin ED, Conners CK, Sparrow E et al. (1996), Nicotine effects on adults with attention-deficit hyperactivity disorder. Psychopharmacology 123(1):55-63.

Lichtermann D, Ekelund E, Pukkala E et al. (2001), Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry 58(6):573-578 [see comment].

Mansvelder HD, McGehee DS (2002), Cellular and synaptic mechanisms of nicotine addiction. J Neurobiol 53(4):606-617.

McEvoy J, Freudenreich O, McGee M et al. (1995), Clozapine decreases smoking in patients with chronic schizophrenia. Biol Psychiatry 37(8):550-552.

McEvoy JP, Freudenreich O, Wilson WH (1999), Smoking and therapeutic response to clozapine in patients with schizophrenia. Biol Psychiatry 46(1):125-129.

McFall M, Saxon AJ, Thompson CE et al. (2005), Improving the rates of quitting smoking for veterans with posttraumatic stress disorder. Am J Psychiatry 162(7):1311-1319.

Newhouse PA, Sunderland T, Tariot PN et al. (1988), Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology (Berl) 95(2):171-175.

Niaura R, Borreli B, Hedeker D et al. (2002), Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment. J Consult Clin Psychology 70(4):887-896.

Niaura R, Britt DM, Shadel WM et al. (2001), Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav 15(1):13-17.

Picciotto MR (2003), Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol Sci 24(9):493-499.

Potter A, Corwin J, Lang J et al. (1999), Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease. Psychopharmacology (Berl) 142(4):334-342.

Sacco KA, Bannon KL, George TP (2004), Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol 18(4):457-474.

Sacco KA, Termine A, Seyal AA et al. (2005), Effects of cigarette smoking function on spatial working memory and attentional function in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 62(6):649-659.

Shoptaw S, Jarvik ME, Ling W, Rawson RA (1996), Contingency management for tobacco smoking in methadone-maintained opiate addicts. Addict Behav 21(3):409-412.

Smith RC, Singh A, Infante M et al. (2002), Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology 27(3):479-497.

Sussman S (2002), Smoking cessation among persons in recovery. Subst Use Misuse 37(8-10):1275-1298.

Thorsteinsson HS, Gillin JC, Patten CA et al. (2001), The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression. Neuropsychopharmacology 24(4):350-358.

Tsoh JY, Humfleet GL, Munoz RF et al. (2000), Development of major depression after treatment for smoking cessation. Am J Psychiatry 157(3):368-374.

U.S. Department of Health and Human Services (2004), Health Consequences of Smoking Cessation: A Report of the Surgeon General. Washington, D.C.: Government Printing Office.

Volkow ND, Fowler JS, Wang GJ (2002), Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav Pharmacol 13(5-6):355-366 [comment].

Williams JM, Ziedonis DM, Foulds J (2004), A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia. Psychiatr Serv 55(9):1064-1066.

Ziedonis DM, George TP (1997), Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophr Bull 23(2):247-254.

Last updated: 1/06

Related Information

top ~ send this page to a friend ~ home

HealthyPlace.com Homepage
Chat ~ Forums ~ Communities
HealthyPlace.com Films ~ HealthyPlace.com Radio ~ News
Site Map ~ Web Tour ~ Advertise ~ Email Us
send this page to a friend

HealthyPlace.com

Information

Community & Events

Comorbid Tobacco Dependence and Psychiatric Disorders

References